Joint Annual Meeting ISMRM-ESMRMB • 16-21 June 2018 • Paris, France
Sunrise Session Assessing Response in Liver Tumors: Primary & Metastatic |
||||||||||||
Assessing Response in Liver Tumours: Primary & Metastatic
Sunrise Session ORGANIZERS: Kathryn Fowler, Kartik Jhaveri, Catherine Hines, Lorenzo Mannelli, Valeria Panebianco, Scott Reeder, Reiko Woodhams
Thursday, 21 June 2018
Skill Level: Intermediate
Session Number: S-Th-01
Overview This course discusses findings in primary and metastatic liver malignancy with regard to assessing response to therapies (both liver-directed and systemic). This course will discuss how to optimize image acquisition for state-of-the-art image quality and as short as possible scan time. Target Audience This course is aimed at radiologists, imaging scientists and MR technologists who wish to review liver cancer imaging for response to therapies. Educational Objectives As a result of attending this course, participants should be able to: -Describe a high quality liver MRI protocol; -Explain the MRI findings involved in diagnosing primary and metastatic liver cancer; -Illustrate the MRI findings of response to chemotherapy for primary liver cancer; and -Illustrate the MRI findings of response to chemotherapy for metastatic cancer to the liver.
|
||||||||||||
Back | ||||||||||||
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |